Who Are We Missing? Reporting of Ethnicity, Race, and Sex‐Specific Populations in Clinical Trials | Journal of the American Heart Association
Low enrollment in randomized clinical trials (RCTs) hinders cardiovascular medicine advances. 1, 2 This disproportionately affects Black, Hispanic and Latino, and female patients who have disproportionately higher rates of cardiovascular risk factors and worse outcomes. 1 Prior studies evaluated individual diseases, limited populations, and older trials, and used prior National Institutes of Health race and ethnicity definitions. 1, 2 Therefore, our objective was to quantitatively evaluate Black,
